Regulatory Affairs Officer (Biovaccines) at May & Baker Nigeria Plc


May & Baker Nigeria Plc was founded on September 4, 1944 as Nigeria's first pharmaceutical company. It has its origin in England, the United Kingdom in 1834 where three chemists founded Grimwade, May & Pickett, a firm for manufacturing chemicals for pharmaceutical products.

We are recruiting to fill the following positions below:

 

Job Title: Regulatory Affairs Officer (Biovaccines)

Location: Yaba, Lagos
Job Type: Full-time

Responsibilities

  • Reporting to the Chief Operating Officer, The Regulatory Affairs Officer will be responsible for all external and internal regulatory compliance for the business.
  • Ensure that all Regulatory Certifications and Operational Permits and Licenses for the Premises, Warehouse and Superintendent Pharmacist are in place.
  • Obtain import permits, endorsements, and prompt removal of hold labels for imported products.
  • Achieve zero incidences of Non-Compliance and Non-Conformance that may lead to fines and penalties.
  • Maintain an updated register of relevant KOL at the respective Regulatory Institutions.
  • Achieve all product Marketing Authorization filing and prompt renewal for both locally manufactured and imported vaccines, as well as for 3rd Party products.
  • Ensure that all product and manufacturing process variations are promptly filed, and approvals obtained from NAFDAC.
  • Any other relevant duties as may be communicated from time to time.

Qualifications

  • Candidates should possess a B. Pharm (preferred) / B.Sc. in Biological Sciences (Microbiology, Biochemistry) with at least 2 years in a similar role.

Role Expectations:

  • Leadership
  • Team player
  • Attention to detail
  • Orderliness
  • Proficiency in computer applications.
  • Effective communication
  • A high level of organisation
  • Record keeping

 

How to Apply
Interested and qualified candidates should send their CV to: [email protected] using the job title as the subject of the mail

Application Deadline 22nd October, 2024.